Sangamo BioSciences | SGMO - Zapasy





Zapasy Zmiana Data
Alnylam Pharmaceuticals USD 200.15M 117.43M 2026-03
Amgen USD 6.19B 39M 2026-03
Bayer EUR 12.34B 3M 2025-12
BioCryst Pharmaceuticals USD 5.98M 587K 2026-03
Biogen USD 1.95B 219.1M 2026-03
BioMarin Pharmaceutical USD 1.27B 25.66M 2026-03
Cipla INR 61.6B 5.18B 2025-09
Clal Biotechnology ILS 4.44M 0 2021-03
CSL USD 6.47B 327M 2025-06
Gilead Sciences USD 1.91B 140M 2026-03
GlaxoSmithKline GBP 6.16B 233M 2026-03
Grifols EUR 3.56B 63.19M 2024-12
Ionis Pharmaceuticals USD 5.56M 4.49M 2026-03
J&J USD 14.58B 392M 2026-03
Karyopharm Therapeutics USD 4.04M 72K 2025-12
Merck USD 6.48B 179M 2026-03
Novartis USD 6.29B 17M 2026-03
Omeros USD 712K 266K 2021-09
Pfizer USD 10.67B 13M 2026-03
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 22.69B 1.81B 2025-12
Sarepta Therapeutics USD 1B 86.37M 2026-03
Ultragenyx Pharmaceutical USD 55M 3M 2026-03
Vertex Pharmaceuticals USD 1.77B 79.9M 2026-03